$0.865
-0.026[-2.92%]
At close: Apr 25
$0.865
0[0.00%]
After Hours: 7:41PM EDT
Microbot Medical
(NASDAQ:MBOT)Microbot Medical Stock (NASDAQ:MBOT), Analyst Ratings, Price Targets, Predictions
Microbot Medical Inc has a consensus price target of $7, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 16, 2024, October 18, 2023, and June 26, 2023. With an average price target of $7.67 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 786.32% upside for Microbot Medical Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Microbot Medical
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/16/2024 | MBOT | Buy Now | Microbot Medical | $0.86 | 709.25% | HC Wainwright & Co. | Raghuram Selvaraju | $8 → $7 | Maintains | Buy | Get Alert |
| 10/18/2023 | MBOT | Buy Now | Microbot Medical | $0.86 | 824.86% | HC Wainwright & Co. | Raghuram Selvaraju | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/26/2023 | MBOT | Buy Now | Microbot Medical | $0.86 | 824.86% | HC Wainwright & Co. | Raghuram Selvaraju | → $8 | Reiterates | Buy → Buy | Get Alert |
| 06/06/2023 | MBOT | Buy Now | Microbot Medical | $0.86 | 824.86% | HC Wainwright & Co. | Raghuram Selvaraju | → $8 | Reiterates | → Buy | Get Alert |
| 05/09/2023 | MBOT | Buy Now | Microbot Medical | $0.86 | 824.86% | HC Wainwright & Co. | Raghuram Selvaraju | $20 → $8 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Microbot Medical (MBOT)?
The latest price target for Microbot Medical (NASDAQ: MBOT) was reported by HC Wainwright & Co. on April 16, 2024. The analyst firm set a price target for $7.00 expecting MBOT to rise to within 12 months (a possible 709.25% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Microbot Medical (MBOT)?
The latest analyst rating for Microbot Medical (NASDAQ: MBOT) was provided by HC Wainwright & Co., and Microbot Medical maintained their buy rating.
When was the last upgrade for Microbot Medical (MBOT)?
There is no last upgrade for Microbot Medical.
When was the last downgrade for Microbot Medical (MBOT)?
There is no last downgrade for Microbot Medical.
When is the next analyst rating going to be posted or updated for Microbot Medical (MBOT)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Microbot Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Microbot Medical was filed on April 16, 2024 so you should expect the next rating to be made available sometime around April 16, 2025.
Is the Analyst Rating Microbot Medical (MBOT) correct?
While ratings are subjective and will change, the latest Microbot Medical (MBOT) rating was a maintained with a price target of $8.00 to $7.00. The current price Microbot Medical (MBOT) is trading at is $0.87, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.